Kyle Smith, PhD
Director, Research and Development
Kyle Smith, PhD, is an engineer and scientist with more than a decade of experience in microfluidics, computational modeling, and early-stage medical device development. While a member of the innovation team at Massachusetts General Hospital, he invented and optimized the ultra-high-throughput microfluidic cell sorting technologies that lie at the heart of MicroMedicine’s products. He also led a team in developing novel, extremely high-sensitivity devices for isolating and analyzing circulating tumor cells, among many other early-stage R&D projects. Kyle received his bachelor’s degree in biomedical engineering from Duke University, his master’s in electrical engineering and computer science from MIT, and his PhD in biomedical and electrical engineering from the Harvard-MIT Division of Health Sciences and Technology, where he held fellowships from the National Science Foundation, Whitaker Foundation, and MIT. His doctoral work focused on the development of sophisticated computational models of electroporation and molecular transport with applications in drug delivery, cancer treatment, and biotechnology. Kyle is a founding team member of MicroMedicine.